Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immuno-oncology
Marketing
Coherus loses commercial chief amid exit from biosimilar space
As the biotech completes its pivot away from biosimilars, Reider has resigned as chief commercial officer to pursue other opportunities.
Nick Paul Taylor
Apr 23, 2025 11:19am
BMS follows Roche, AstraZeneca into first-line liver cancer
Apr 11, 2025 1:53pm
ImmunityBio, SII win FDA nod to help combat BCG shortage
Feb 19, 2025 9:01am
Agenus to offer CDMO services, lay off staffers in latest reorg
Dec 5, 2024 7:51am
Coherus sells Neulasta biosimilar to Intas for up to $558M
Dec 3, 2024 4:16pm
Incyte touts 2 trial wins for PD-1 drug Zynyz amid I-O retreat
Jul 30, 2024 11:27am
